Since Medicare Part D was created, seniors and people living with disabilities have been assured appropriate access to six specific classes of medicines (also known as the protected classes). The six protected classes help ensure patient access to medications, which in turn helps them maintain their often extensive or complicated treatments associated with diseases like:
- mental illness
- those undergoing organ transplantation
This important policy allows patients to access, “all or substantially all” medications within these categories regardless of price, which gives patients the critical ability to maintain specific drug regimens prescribed by their doctors. Further, this access helps ensure patients are adherent to the medicines they need to manage chronic conditions and live longer, healthier lives.
Andrew Powaleny Andrew Powaleny is Director of Public Affairs at PhRMA. Before joining PhRMA in 2015, he worked at the House Energy and Commerce Committee and later as a communications consultant. Andrew came to Washington, D.C. via Connecticut and proudly runs with the DC Front Runners and serves as its co-race director. He is also a member of the National Lesbian Gay Journalists Association and a proud alum of The Fund for American Studies. He’s passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.